GU Cancers 2020 | Cytoreductive nephrectomy for RCC

Ziad Bakouny

Ziad Bakouny, MD, Dana-Farber Cancer Institute, Boston, MA, discusses his analysis of cytoreductive nephrectomy for metastatic renal cell carcinoma (RCC) treated with immune checkpoint inhibitors or targeted therapy. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter